Skip to main content
Springer Nature Link
Log in

A mathematical study for the development of anti-HIV-1 therapies based on the lethal mutagenesis method

  • Original Article
  • Published:
Artificial Life and Robotics Aims and scope Submit manuscript

Abstract

This study tried to mathematically unveil the difficulties associated with an anti-HIV therapy based on the lethal mutagenesis method; two difficulties were identified. The first difficulty of this method was that the efficacy of a mutagen must be over a certain threshold to treat HIV-1 infection, which could explain the apparent failure of the KP-1461 trial. Furthermore, we investigated the influence of the latency of HIV-1 on the treatment period and clarified that the latency increases the treatment period in a manner almost independent of the efficacy of a mutagen. This is the second difficulty associated with the lethal mutagenesis method.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Explore related subjects

Discover the latest articles, news and stories from top researchers in related subjects.

References

  1. WHO (2018) Development of the global action plan on HIV drug resistance, 2017-2021. 12:11. Available from: http://www.who.int/hiv/drugresistance/hivdr-action-plan-2017-2021/en/. Accessed 5 Dec 2019

  2. Loeb LA, Essigmann JM, Kazazi F et al (1999) Lethal mutagenesis of HIV with mutagenic nucleoside analogs. Proc Natl Acad Sci USA 96:1492–1497

    Article  Google Scholar 

  3. Iyidogan P, Anderson KS (2014) Current perspectives on HIV-1 antiretroviral drug resistance. Viruses 6(10):4095–4139. https://doi.org/10.3390/v6104095

    Article  Google Scholar 

  4. Mullins JI, Heath L, Hughes JP et al (2011) Mutation of HIV-1 genomes in a clinical population treated with the mutagenic nucleoside KP1461. PLoS One 6(1):e15135. https://doi.org/10.1371/journal.pone.0015135

    Article  Google Scholar 

  5. Sedaghat AR, Siliciano RF, Wilke CO (2008) Low-level HIV-1 replication and the dynamics of the resting CD4 + T cell reservoir for HIV-1 in the setting of HAART. BMC Infect Dis 8:2. https://doi.org/10.1186/1471-2334-8-2

    Article  Google Scholar 

  6. Callaway DS, Perelson AS (2002) HIV-1 infection and low steady state viral loads. Bull Math Biol 64(1):29–64

    Article  Google Scholar 

  7. Mansky LM, Temin HM (1995) Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol 69(8):5087–5094

    Article  Google Scholar 

  8. Alligood KT, Sauer TD, Yorke JA (2000) Chaos: an introduction to dynamical systems. Springer, New York

    MATH  Google Scholar 

  9. Finzi D, Blankson J, Siliciano JD et al (1999) Latent infection of CD4 + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med 5(5):512–517. https://doi.org/10.1038/8394

    Article  Google Scholar 

  10. Guochun J, Erica AM, Philipp K et al (2015) Synergistic Reactivation of latent HIV expression by ingenol-3-angelate, PEP005, targeted NF-kB signaling in combination with JQ1 induced p-TEFb activation. PLoS Pathog 11(7):e1005066. https://doi.org/10.1371/journal.ppat.1005066

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Computer Science and Engineering, Toyohashi University of Technology, Toyohashi, Japan

    Kouji Harada

Authors
  1. Kouji Harada
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Kouji Harada.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Harada, K. A mathematical study for the development of anti-HIV-1 therapies based on the lethal mutagenesis method. Artif Life Robotics 25, 273–277 (2020). https://doi.org/10.1007/s10015-019-00578-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10015-019-00578-2

Keywords